The 2011 revision to the ANTITRUST DIVISION POLICY GUIDE TO MERGER REMEDIES (REMEDIES GUIDE) is notable in that it signals a shift in the Department of Justice's (DOJ's) approach to merger remedies. The earlier REMEDIES GUIDE, issued in 2004, emphasized structural remedies such as divestitures as the preferred approach to resolving competitive problems with mergers. In contrast, the 2011 revision is considerably more favorably disposed toward the use of behavioral remedies that proscribe specified anticompetitive behaviors of the merged companies.
Executive Summary
The 2011 revision to the ANTITRUST DIVISION POLICY GUIDE TO MERGER REMEDIES (REMEDIES GUIDE) is notable in that it signals a shift in the Department of Justice's (DOJ's) approach to merger remedies. The earlier REMEDIES GUIDE, issued in 2004, emphasized structural remedies such as divestitures as the preferred approach to resolving competitive problems with mergers. In contrast, the 2011 revision is considerably more favorably disposed toward the use of behavioral remedies that proscribe specified anticompetitive behaviors of the merged companies.
The 2011 REMEDIES GUIDE expands the types of behavioral remedies that the DOJ states the agency will consider, providing for relatively more complex, interventionist, and ongoing restraints. This stands in contrast to past behavioral remedies that were generally limited in scope and ancillary to other provisions of consent orders. This apparent policy shift is illustrated by the behavioral remedies employed by the DOJ in three recent merger cases -Ticketmaster-Live Nation, Comcast-NBCU, and Google-ITA. These three cases involve the use of multiple behavioral remedies, ranging from access conditions (e.g., licensing and non-discrimination requirements), firewalls, anti-retaliation provisions, to arbitration requirements, and provide for monitoring and compliance enforcement.
The expansive new approach to behavioral remedies raises a number of concerns about their likely operation, effectiveness, and requirements for ongoing government monitoring and compliance enforcement. Many of these issues are similar to problems encountered in traditional industry regulation, ranging from countervailing incentives to implementation costs. Behavioral remedies also pose practical problems for antitrust 1 John E. Kwoka is the Neal F. Finnegan Professor of Economics, Northeastern University and Diana Moss is Vice President and Director, American Antitrust Institute (AAI). John Kwoka served as consultant to the states in the Ticketmaster-Live Nation matter. Analysis contained herein regarding the case is based on public information and focuses on issues subsequent to that consultancy. Many thanks to Randy Stutz, Special Projects Director, AAI, for the summary of the Google-ITA case, to Bert Foer for helpful review of earlier drafts, and to Ke Li for research support. The AAI is an independent non-profit education, research, and advocacy organization. Its mission is to advance the role of competition in the economy, protect consumers, and sustain the vitality of the antitrust laws. AAI is managed by its Board of Directors, which alone has approved of this White Paper. For more information, see www.antitrustinstitute.org. enforcement, including tensions created by blending prosecutorial and compliance functions within the Antitrust Division of the DOJ and the difficulties of "testing" their effectiveness to ensure best practices.
How well the packages of behavioral remedies function to restore competition in the markets affected by the three particular mergers examined in this White Paper remains to be seen. Nonetheless, it identifies a number of issues that warrant attention and prompt some concern and based on this early analysis, a number of observations and policy recommendations would seem justified.
I. Introduction
The U.S. antitrust agencies periodically issue revisions of various merger policy guidelines in order to better reflect changes in practice and advances in analytical The REMEDIES GUIDE is notable in that it signals a shift in the DOJ's approach to merger remedies. The earlier REMEDIES GUIDE, issued in 2004, emphasized structural remedies such as divestitures as the preferred approach to resolving competitive problems with mergers. In contrast, the 2011 revision is considerably more favorably disposed toward the use of behavioral remedies that proscribe specified anticompetitive behavior of the merged companies. Such remedies are now endorsed more widely for vertical mergers, where current policy is commendably more active than in the past. Moreover, their potential use would not seem to be restricted to vertical cases. This policy revision is reflected in three recent mergers that in quick succession have all been permitted subject to consent orders with substantial behavioral remedies. These are the mergers of Ticketmaster-Live Nation, Google-ITA, and Comcast-NBCU. The 2011 REMEDIES GUIDE essentially codifies much of the approach adopted in these merger cases.
This White Paper takes a closer look at these new developments in merger remedies. It begins in Section II by examining the shift toward behavioral remedies in the 2011 REMEDIES GUIDE. It discusses the merits of structural versus behavioral remedies and the basis for past preference for structural remedies in the U.S. and in other major competition jurisdictions. Section III reviews three recent merger cases that were resolved with behavioral remedies. These case studies encapsulate the breadth of the DOJ's revised approach. Section IV analyzes in detail the difficulties associated with behavioral remedies by drawing parallels with well-known challenges faced by economic regulation. Section V concludes with policy recommendations.
II. Structural Versus Behavioral Approaches to Merger Remedies

A. Structural Versus Behavioral Remedies
The literature contains several alternative definitions of structural versus behavioral remedies, 3 but most have at their core the following distinction: a structural remedy to an otherwise anticompetitive merger creates or preserves legally and operationally independent firms so as to maintain competition in the affected market. By contrast, a behavioral remedy permits integration subject to operating rules intended to prevent the merged firm from subsequently undermining market competition. competitor and thereby replace the competition otherwise lost as a result of the merger. In principle, once created, the divested entity will act as an independent firm, seeking to maximize profit by engaging in the same competitive actions as other firms in the market.
Moreover, once such a new firm is created, there typically is no on-going oversight or other action required of the competition authority, and no constraints or reporting requirements on the firm. There are countless examples of divestitures in antitrust caseseither offered up front by the merging parties (so-called "fix it first") or negotiated as part of a settlement process -but most have these stated characteristics.
By contrast, behavioral remedies -sometimes called "conduct" or "nonstructural" remedies -allow the parties to integrate fully, but then impose certain operating rules on their business behavior so as to prevent competition from being undermined or compromised. In short, these remedies seek to permit the merger to achieve efficiencies but without the anticompetitive behavior the firm would otherwise engage in. Depending on the perceived threat, these rules can take several different forms. Some, like information firewalls, constrain the internal operation of the firm, while others -illustrated by non-retaliation rules -are directed at the firm's behavior toward external rivals.
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The common feature of behavioral remedies is that they are in effect attempts to require a merged firm to operate in a manner inconsistent with its own profit-maximizing incentives. But allowing the merger and then requiring the merged firm to ignore the 4 Structural and behavioral remedies can also be combined in a "hybrid" approach. It should also be noted that some remedies defy easy classification. For example, while the 2011 Remedies Guide terms licensing of intangible assets (e.g., patent rights) a divestiture remedy, such a provision in the Google-ITA consent is not so labeled.
incentives inherent in its integrated structure is both paradoxical and likely difficult to achieve. Furthermore, the behavior that such remedies seek to prohibit or require is often difficult to fully specify, leading to subsequent enforcement issues. In some cases, the behavior may be so integral to the firm that it may be unrealistic to suppose the firm can avoid it. As a result, behavioral rules usually must be supplemented with close and ongoing oversight of the merged firm's actual conduct, typically relying upon a monitor with authority to require reports and perhaps to intervene in the decision-making of the merged firm.
B.
Revised DOJ Remedies Guidelines and Behavioral Approaches
Substantive Changes in the DOJ REMEDIES GUIDE
The policy shift in the DOJ's 2011 REMEDIES GUIDE is revealed in several major differences relative to the 2004 REMEDIES GUIDES. First, gone from the new REMEDIES GUIDE is any specific statement of preference for structural remedies and the appropriateness of behavioral relief in only limited circumstances. Replacing that is the statement that: "In certain factual circumstances, structural relief may be the best choice to preserve competition. In a different set of circumstances, behavioral relief may be the best choice." 5 The 2011 REMEDIES GUIDE goes on to state only that structural remedies "often" suffice in horizontal cases, but that in vertical cases conduct remedies "often" address competitive concerns, sometimes in conjunction with structural remedies. 6 In taking this position, it moves away from a strong structural emphasis to a more case-bycase approach involving conduct remedies.
5 2011 REMEDIES GUIDE, supra note 2, at 4.
6 Id. at 2.
Second, the 2011 REMEDIES GUIDE contains a separate and expanded section on behavioral remedies and a new section on hybrid remedies. Much of the valuable guidance on structural divestiture passes intact from the 2004 to the 2011 REMEDIES GUIDE. However, the new REMEDIES GUIDE is discernibly more optimistic than its predecessor regarding the role of behavioral remedies. They are declared to be a "valuable tool" in remedying a merger's competitive harm while preserving its potential efficiencies. 7 The behavioral approach is specifically endorsed for vertical mergers and for mergers with both horizontal and vertical components. Altogether missing from the 2011 REMEDIES GUIDE is any mention of four substantial costs associated with behavioral remedies, namely, the direct costs of monitoring, the costs of evasion, the potential to restrain procompetitive behavior, and the difficulty of adaptation to changing market conditions. 8 While these were central to the 2004 REMEDIES GUIDE approach, that discussion is deleted without explanation of the basis for changed thinking.
Third, the 2011 REMEDIES GUIDE expands the types of behavioral remedies that the DOJ states it will consider. In addition to firewalls, transparency provisions, and nondiscrimination provisions, the revision also discusses possible use of mandatory licensing, anti-retaliation, prohibitions on certain contracting practices, and arbitration requirements as part of non-discrimination provisions. These go beyond past DOJ statements and practices with respect to merger remedies.
Finally, a section on compliance discusses remedies enforcement. It observes that enforcement is dependent on the allocation of internal Antitrust Division resources to the 7 Id. at 6-7.
development of best practices and ex post reviews of remedies effectiveness. It does not address the question of where such resources will be found.
Analysis of the DOJ's New Approach to Behavioral Remedies
The new approach to remedies stands in contrast not only with structural remedies -which require no subsequent oversight -but to some degree also with instances where behavior-oriented remedies have been used in the past. Past behavioral remedies were generally restricted to vertical mergers, were limited in scope, and were ancillary to other provisions of the consent orders. Newer behavioral remedies are not so limited in their application, and involve relatively more complex, interventionist, ongoing restraints.
More specifically, these new behavioral remedies differ in several respects. They are different in that they stand at the core of merger resolution, so the effectiveness of the settlement rises or falls with their effectiveness. They are different in that they are being used not simply in network or infrastructure industries, as has sometimes been the case before, but in more traditional horizontal mergers. 9 They are different in that they intervene more deeply and broadly into the operations of the merged firms, seeking to blunt anticompetitive incentives at a more fundamental level. And they are different since collectively they require novel forms of oversight and expanded resource commitment by the DOJ. buyers; incentives for the merging parties to dispose of assets so as to not fully restore competition; market structure post-remedy; and the conduciveness of the market to collusion following an asset sale. 17 The track record of structural remedies in the U.S. has been examined by the FTC in a study that found only a minority of remedies were successful in fully restoring the competition lost by a merger. 18 Importantly, however, that study linked such failures to the improper framing of structural remedies and offered a number of recommendations for improvements in policy. Those recommendations have been implemented and have improved subsequent policy with respect to merger remedies.
C. Preference for Structural Remedies in the U.S. and Other Major Jurisdictions
As noted, the 2004 REMEDIES GUIDE expressed a clear preference for structural remedies, citing "speed, certainty, cost, and efficacy" as key factors by which the potential effectiveness of a remedy should be measured. 19 By way of explanation, the 2004 REMEDIES GUIDE stated that structural remedies were preferred to behavioral remedies because:
… they are relatively clean and certain, and generally avoid costly government entanglement in the market. A carefully crafted divestiture decree is "simple, relatively easy to administer, and sure" to preserve competition.
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This preference for structural remedies was illustrated in countless merger cases both before and after issuance of the 2004 REMEDIES GUIDE.
In this approach, U.S. policy was consistent with the enforcement posture in Canada, the European Union, United Kingdom, and Canada. In 2001, the European Commission stated:
…Commitments that are structural in nature, such as the commitment to sell a subsidiary, are, as a rule, preferable from the point of view of the Regulation's objective, inasmuch as such a commitment prevents the creation or strengthening of a dominant position previously identified by the Commission and does not, moreover, require medium or long-term monitoring measures.
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The UK Competition Commission expressed a similar preference in 2008 in this way:
In merger inquiries, the CC will generally prefer structural remedies, such as divestiture or prohibition, rather than behavioral remedies because: (a) structural remedies are likely to deal with an SLC [substantial lessening of competition] and its resulting adverse effects directly and comprehensively at source by restoring rivalry; (b) behavioral remedies may not have an effective impact on the SLC and its resulting adverse effects, and may create significant costly distortions in market outcomes; and (c) structural remedies do not normally require monitoring and enforcement once implemented. In sum, it is clear that structural remedies have been the preferred method of resolving concerns with a proposed merger. Limitations with structural remedies do exist, but these have been identified and at least to some degree addressed. As discussed in Section IV, it is less clear that the significant disadvantages of behavioral remedies can similarly be resolved. 
III. Recent Case Studies of Behavioral Remedies
The more favorable view of behavioral remedies in the 2011 REMEDIES GUIDES is not simply a statement of policy. Rather, it has already been implemented in three merger cases that were decided in quick succession by the DOJ. These three cases are
Ticketmaster-Line Nation, Comcast-NBCU, and Google-ITA. The intended scope and the practical difficulties associated with behavioral remedies are clearly illustrated by these cases.
A. Ticketmaster-Live Nation
In early The threshold competitive issue concerned the effect of combining Ticketmaster's dominant position in primary ticketing services with Live Nation's significant upstart competitive service. The proposed merger would therefore eliminate the only sizeable horizontal competitor (or potential competitor) to Ticketmaster's dominant position. The potential adverse effects would not be remedied by entry, as DOJ noted several significant impediments. Paramount among these was the fact that major venues were reluctant to contract for ticketing services with providers who might not be able to handle the demands of major events. The transaction clearly would also increase the degree of vertical control. No rival at any stage would be able to avoid transacting with a merged Ticketmaster-Live Nation for necessary related services, and that necessity would create considerable potential for several types of mischief toward rivals and harm to consumers.
The first was the possibility that Live Nation would use competitively sensitive information about the artists, venues, and fans, to the competitive disadvantage of promoters that placed artists at venues serviced by Ticketmaster. A second concern was the possibility that the merged firm's artist management arm "Front Line" might steer artists to its own promotion operation, or that venues that did not sign Front Line talent might find their access to other concert talent restricted. The third centered on the possibility that independent rivals might find that if they became too aggressive in competing with the merged entity, Ticketmaster-Live Nation could make it difficult for them to secure artists or concerts or venues.
Although the parties claimed significant cost savings from vertical integration, as well as revenue synergies from being able to market more effectively to fans, the DOJ viewed these claims skeptically. It noted that each company already was significantly integrated, and that absent the merger, "venues and concertgoers would have continued to enjoy the benefits of competition between two vertically integrated competitors." Despite these concerns, the DOJ approved the merger, subject to conditions directed at both the horizontal and vertical issues, effective for 10 years. To replace the lost horizontal competition, DOJ required the licensing of the basic ticketing platform (Host)
to AEG -the second leading concert promoter and operator of a number of major venues -in the belief that AEG would have strong incentives to utilize Host both to do its own ticketing and to compete for new ticketing business. The consent order also required the divesture of Paciolan, the venue-based ticketing division, to Comcast-Spectacor, a small and primarily regional ticketing service.
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To address vertical concerns, DOJ prohibited the merged firm from several specific actions: (1) retaliation against venue owners who contracted for primary ticketing services with a rival; (2) any requirement that a venue use its primary ticketing services when that venue wanted only to obtain concerts promoted by the merged firm;
(3) any requirement that venues take the merged firm's concerts as a condition for obtaining ticketing services; and (4) using ticketing data in their non-ticketing businesses. Despite these concerns, the DOJ reached a settlement allowing the merger to proceed, subject to certain behavioral remedies that would be in effect for seven years.
B. Comcast-NBCU
The most important of the remedies outlined conduct that was required, prohibited, or permitted. The affirmative conduct requirements created a non-discrimination regime, including the required provision of "economically equivalent" and "comparable" video programming to OVDs. 34 The consent decree attempted to define and set parameters for non-discrimination conditions. For example, economic equivalence was defined as the prices, terms, and conditions that "in the aggregate, reasonably approximate" those on which the JV provided programming to an MVPD. "reasonably similar in kind and amount, considering the volume and its value" to that which an OVD received from a peer. 36 Programming provided by the JV to Hulu was to be comparable in terms of "type, quantity, ratings, and quality" and provided on "substantially the same terms and conditions as were in place on January 1, 2011." Id. at 5,462 § IV(G).
Kayak and Bing Travel. The transaction was difficult to characterize in that the merging parties did not directly compete or even fit together vertically in an existing supply chain.
Moreover, the risk of anticompetitive effects was strongest in a market -flight search services -that neither party had entered pre-merger or would necessarily enter postmerger. But Google had both the ability and the intent to develop a comparative flight search services product incorporating QPX technology, and by doing so it would place itself in direct competition with customers of ITA.
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In its Complaint, the DOJ identified two relevant product markets -a P&S system market and a comparative flight search market -each of which was nationwide in geographic scope. The comparative flight search market included both OTAs and Metas, but excluded airline sites, which are not good substitutes for OTIs. The DOJ emphasized that QPX was a critical flight search tool for which OTIs currently had no adequate alternatives. 39 The agency identified a post-merger incentive for Google to foreclose or disadvantage rival OTIs' access to QPX, the concomitant risk of reduced innovation among travel websites, and the potential to unfairly raise rivals' costs and harm consumer choice. 40 The DOJ characterized entry barriers into the P&S system market as "extremely high," supported by the failure of two start-up firms to gain any meaningful OTI market share and the time required for Google itself to develop its own P&S system. 41 Moreover, the DOJ argued that the transaction would raise entry barriers in the comparative flight search market by placing QPX out of the reach of potential entrants.
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The remedy reflected in the consent order consisted entirely of behavioral relief, to be effective for five years. It featured a mandatory licensing component, a quality-ofterms component, maintenance and R&D commitments, a dispute resolution mechanism, a series of explicit behavioral prohibitions, a set of affirmative behavioral obligations, monitoring and compliance provisions (including arbitration), and modifiable firewall protections to address the possible exchange of competitive sensitive information regarding OTIs.
From an upstream perspective, the settlement obligated Google to continue licensing both ITA's existing QPX product and its future "InstaSearch" product to OTIs on fair, reasonable and non-discriminatory price and non-price terms. 43 From a downstream perspective, the decree prohibited Google from entering agreements that would restrict the rights of airlines to share certain data with parties other than Google, obliged Google to include certain airline data in the P&S system results generated for all OTIs, and prohibited Google from tying the sale of ITA products and services to the purchase of other Google products and services. 
IV. Evaluation and Implications of Behavioral Remedies
The new behavioral remedies raise a number of practical problems. Here those problems are discussed in detail, by drawing an analogy between behavioral remedies and traditional regulation. This is followed by a discussion of enforcement concerns.
A. Parallels Between Economic Regulation and Behavioral Remedies
The characteristics of the new behavioral remedies -their scope, their intrusiveness, the need for on-going oversight -raise a number of significant concerns about their likely operation and effectiveness. Significantly, many of these concerns are What is striking about this analogy is that traditional regulation has come to be widely known for various inherent limitations, administrative costs, and unintended effects. Indeed, much of the modern economic theory of regulation examines the forces and conditions that handicap regulatory authorities and undermine the effectiveness of regulatory policy. And a great many economic studies have demonstrated the practical problems inherent in any effort to constrain normal profit-maximizing behavior by use of rules and oversight. Considerable empirical evidence establishes a very mixed record for modifying the behavior of regulated firms in many industries, and the frequent distortionary effects of regulatory constraints. 46 These concerns would seem to make regulation-like remedies a questionable model for effective merger control.
Next we examine some specific difficulties faced by the new behavioral remedies that echo those of traditional regulation. Ticketmaster-Live Nation and Comcast-NBCU consent orders may seem straightforward, but in actual practice, disentangling the firm's motives for a specific action in order to determine whether it is properly characterized as "retaliatory" is not straightforward. This informational asymmetry is analogous to that in the context of traditional regulation. There a key asymmetry involves the firm's costs, which the company understands far better that the regulator, but which the regulator needs to ascertain in order to establish price and allowed profit. A further asymmetry arises in making judgments about the motivation for certain actions by the company. In electricity markets, for example, strategic withholding of supply in order to drive up price in periods of scarcity is formally prohibited in most organized markets, but what constitutes strategic withholding versus supply reductions for ordinary business reasons is often 47 In Ticketmaster-Live Nation, for example, retaliation is defined as "refusing to provide live entertainment events, or providing live entertainment events to a venue owner on less favorable terms, for the purpose of punishing or disciplining a venue owner because the venue owner has contracted for or is contemplating contracting with a company other than defendant for primary ticketing services. The term 'retaliate' does not mean pursuing a more advantageous deal with a competing venue owner." It takes little creativity to envision the various ways in which a particular action might be interpreted differently under this statement. United States v. Ticketmaster Entm't, Inc., 75 Fed. Reg. 6,715, 6,716 (DOJ Feb. 10, 2010) (final proposed judgment)..
Asymmetry of Information
beyond an outsider's (i.e., regulator's) ability to distinguish. That leaves a considerable opportunity for the utility to manipulate the system. 48
Inherently Unspecifiable Aspects of the Order
Consent orders prescribe or proscribe behavior in the face of possible complexity of the product, the transaction, the relationship to rivals, and uncertainty about the future.
Each of these dimensions adds to the difficulty of fully specifying the conduct in question, and consent orders become complex insofar as they attempt to set forth as many dimensions and contingencies as possible. Case studies such as Google-ITA highlight the complexities associated with such agreements, including the many exceptions and provisos whose meanings and effects are not easily ascertainable. It therefore seems likely that enforcers, as basically outsiders, will not be able to successfully specify all aspects of the conduct in question. Moreover, they will not be able to foresee future developments that may affect the settlement provisions. While the use of monitors might be helpful in that they permit real-time judgments about these matters, that process too is cumbersome and uncertain in its effectiveness. All of these factors increase the likelihood that enforcers will miss important nuances and that the consent order will bind less tightly than intended.
Difficulty in fully specifying the consent order is analogous to another information problem in traditional regulation -the difficulty faced by the regulator in fully specifying the product or service to be performed. Thus, while "price" may be specifiable, "quality" is less so, with the result that the contract with respect to quality is "incomplete" and may not be fulfilled As shown by price caps in telecom and electricity, even if the regulated firm sets prices as intended, quality may decline since that raises profit. But quality is less easily identifiable to the regulator. 49 The parallels to the antitrust context are clear. The 2011 REMEDIES GUIDE recognizes the problem in stating:
"Remedial provisions that are vague or that can be construed when enforced in such a manner as to fall short of their intended purposes can render useless the enforcement effort." 50 But calls for effective provisions cannot escape the fact that some issues simply cannot be fully specified, regardless of the agency's effort, thus rendering such orders potentially "useless."
Countervailing Incentives
Consent orders can require or prohibit specific behavior, but they cannot abolish the merged firm's incentive to maximize profit, especially when some of the proscribed behavior would seem perfectly normal. Thus, the firm subject to such an order will persistently confront opportunities to use information, develop business practices, or interact with competitors in ways that would increase its profits but that are prohibited by the consent order. For example, information firewalls in Google-ITA and Comcast-NBCU clearly impede the joint operation and coordination of business divisions that would otherwise naturally occur. Non-discrimination provisions in Ticketmaster-Live Nation and other cases require even-handed treatment even though the merged company has more leverage against some businesses relative to others. Such provisions require the firm to "leave money on the table." The firm may therefore be expected to crowd the boundaries of the consent decree and search for alternative methods of achieving the same objectives.
Although the 2011 REMEDIES GUIDE acknowledges the problem of attempted "circumvention of the decree," 51 it does not address the difficulty of preventing such actions. Those difficulties are illustrated by mandatory licensing fees or nondiscrimination provisions which usually rely on language requiring "commercially reasonable" terms or "substantially the same" treatment of rivals. The meaning of such language in actual practice, however, is inherently debatable, with the result that the merged firm may well be able to evade or at least minimize the effect of the order. 
Implementation Costs
On-going oversight of a growing number of consent orders is likely to be a resource-intensive exercise, and the source of the necessary funding is unclear. It may be possible to extract the necessary resources from the parties, or it might be the case that 51 Id., at 13. the agency obtains additional budgetary resources for these purposes. But it is more likely the case that the necessary resources come in large part from the agency's existing budget, implying a trade-off against its other enforcement activities and initiatives.
Based on evidence from traditional regulation, the amounts may be considerable.
Close to 15 percent of the Federal Energy Regulatory Commission's (FERC's) and FCC's budgets for 2010, for example, were devoted to oversight and enforcement.
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While the regulation engaged in by these agencies differs from that which the antitrust agency might do, the indisputable costs of adopting this approach must be recognized.
Moreover, these cost implications are exacerbated by the fact that the expertise and structures of the antitrust agencies are not those of a regulator, but rather they are designed for the purpose of case-specific investigations. Developing the necessary capabilities may require institutional changes, at further cost in terms of time, dollars, and foregone alternatives.
Noncompliance and Arbitration
The reporting and non-compliance problems that accompany traditional regulation are also likely to attach to behavioral remedies. For example, since the antitrust agencies do not have the resources of sector regulators to monitor and oversee compliance, behavioral settlements rely largely on the reporting of problems by adversely affected parties to reveal non-compliance. That implies that the effectiveness of antiretaliation clauses are potentially limited by the risks confronting the "victims" who come forward (e.g., jeopardizing their commercial relationships deals between the merged firm and rivals can also discourage reporting of noncompliance.
In anticipation of the disputes that are sure to arise, settlements may rely on arbitration. As demonstrated by the Google-ITA and Comcast-NBCU consent decrees, however, arbitration is likely to be costly, may well be ineffective, and seems likely to delay the realization of benefits from the restraints. Importantly for investment decisions, the element of predictability is also likely to be sacrificed under arbitration. This concern was captured in the court's reaction to the arbitration requirement in the Comcast-NBCU settlement:
… the Government, at the public hearing, freely admitted that "[w]e can't enforce this decree." In addition, it is undisputed that neither the FCC nor the Department of Justice has any experience yet in administering either course of arbitration in the online-video-distribution context (citation omitted).
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It should also be noted that arbitration often outsources regulatory decisions involving a substantial amount of discretion to a process that is unfamiliar to either regulation or antitrust, posing a challenge to competition policy. Moreover, with the government taking itself out of the picture, there is no party at the arbitration table that represents the public/competition interest.
Term of the Remedy and Dynamic Markets
As previously noted, effective consent orders require foresight to anticipate future market conditions, firm operations and parameters, and even the regulatory system in arguably greater in nascent or dynamic markets such as those at issue in Comcast-NBCU and Google-ITA. Indeed, the 2004 REMEDIES GUIDE clearly recognized these problems, stating that "…even where 'effective,' efforts to regulate a firm's future conduct may prevent it from responding efficiently to changing market conditions."
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Moreover, it is not clear how a limited-term remedy addresses entrenched market power -such as Comcast's or Google's dominance -or even how the term of the remedy should be chosen to allow for needed entry and innovation. For example, in Google-ITA, a relative short consent order "window" decreases the probability that entrants will scale high entry barriers and increases the risk that incumbents scale back investment or even exit the market. 55 Indeed, behavioral remedies that are intended to foster the entry or growth of competitors should be viewed with skepticism, as they depend not only on independent decisions by non-parties, but over time will be subjected to exogenous forces that are difficult to predict.
A behavioral remedy must therefore navigate the twin risks of not committing itself sufficiently into the future, versus imposing restraints that will lock the parties (and the market) into a static or incorrect set of assumptions. The latter could unduly shape or constrain how competition develops, or constrain entry and innovation. Avoidance of these risks requires the agency, at a minimum, to devote resources to the ongoing 54 2004 REMEDIES GUIDE, supra note 2, at 8. 55 The Division notes in its Competitive Impact Statement that "Five years will provide those OTIs that do not wish to be dependent on Defendants' P&S system a sufficient period of time to switch to an alternative system." United States v. Google, Inc., 76 Fed. Reg. 21,020, 21,023 (DOJ April 14, 2011 ) (competitive impact statement).
monitoring of the industry so that it might go back to court if adjustments to the order seem appropriate.
A further important issue over time is that the agency itself changes -in its leadership, in its policies, and in its approaches. As a result, there is less certainty about the actual future effect of a behavioral remedy than there is with respect to divestiture.
The latter is a one-off event, unlikely to be reviewed or reversed, whereas a behavioral remedy is an on-going matter between the agency and the merged firm. Apart from any effort by the latter to relax the restraint, the agency itself may change its view of the consent order or face constraints on its ability to enforce it. These possibilities make any consent order currently imposed subject to considerable uncertainty about its future effect. In all these respects, too, behavioral remedies have much in common with traditional regulation. Difficulties with forecasting, forward-looking parameters, commitment, and predictability are all familiar problems in the regulatory process.
B. Major Issues for Enforcement
Behavioral remedies raise a number of additional issues specifically with respect to enforcement. Many of these flow not from the similarities between antitrust and regulatory enforcement, but from their differences. Three of these are: (1) 
Coordination with Regulatory Agencies
In cases where a sector regulator also has statutory authority to review a merger, 58 At a more microscopic level, litigating attorneys in a government agency are likely to disfavor being compliance "officers," since it is generally not a good way to build a reputation or move up in the ranks.
2011 REMEDIES GUIDE explains that the presence of sector regulation might make the implementation of antitrust remedies more efficient. 59 However possible that may be, the court's skepticism over the arbitration requirement and enforceability of the consent decree in Comcast-NBCU caution against any such presumption. Indeed, agency coordination may also create tensions.
For example, regulators such as the FCC and FERC will almost always impose behavioral remedies if a merger cannot otherwise be found to be in the public interest.
The antitrust agency must then decide whether to take a similar approach or pursue structural remedies that could nullify, or even require the agency to mount a legal challenge to the regulatory conditions. The procedural inefficiency and conflicts that could result from such disparities could put pressure on the antitrust agency to opt for behavioral remedies. The coordination question is complicated by Supreme Court decisions in Trinko and Credit Suisse, which could be read to imply that if a regulatory agency has authority to regulate competition, then the DOJ is preempted, even if there is an antitrust savings clause in the authoritative statute. but without attempting their use, no data can be collected. The policy prescription in most such cases is to "go slow." However, as noted earlier, the DOJ imposed behavioral remedies in three major cases within an 18-month period, one of which involved a complex and relatively novel case of coordinating remedies with a regulatory agency.
And those remedies were soon codified in a new policy guide.
This rapid progression of events raises a number of concerns in light of the fact that the 2011 REMEDIES GUIDE makes no substantive provisions for evaluating the newly endorsed behavioral remedies. It simply notes that compliance with prohibited and affirmative acts can be "monitored" by the staff. 61 In contrast, the REMEDIES GUIDE addresses in considerable detail implementation issues relating to structural remedies, largely because of accumulated experience and the benefit of organized retrospectives.
The absence of a similar implementation framework for behavioral remedies could have a significant impact on their effectiveness in light of two important issues.
First, it is not yet clear how aggressively behavioral remedies will be enforced and how potential conflicts between agencies will be resolved, particularly as agency leadership and priorities change over the span of the consent order. Second, there is relatively little experience with monitoring how well a behavioral remedy restores competition and a scarcity of retrospectives on the use of behavioral remedies. For example, a major type of behavioral remedy is the non-discrimination condition, which is designed to replace competition lost as a result of the merger by requiring the merging parties to give rivals access to or interoperate with certain segments of their system. lobby in settlement proceedings for certain types of behavioral restraints because they allow the merged firm to more easily pursue profit-maximizing behavior.
V. Observations and Policy Recommendations
Whether the types of behavioral remedies set forth in the 2011 Remedies GUIDE and implemented in consent decrees in three recent merger cases will gain a lasting foothold remains to be seen. To this point there is no evidence on the efficacy and effectiveness of these remedies, and so it is premature to decide whether they will prove successful in restoring the competition lost in such mergers. This White Paper has nonetheless identified a number of issues that warrant attention and prompt some concern. Based on this early analysis, a number of observations and policy recommendations would seem justified.
• To the extent possible, structural remedies should be applied. In limited cases where such remedies are difficult to craft, behavioral remedies may be acceptable. Structural remedies have advantages in terms of clarity, cost, and certainty, and have withstood the test of experience. They should arguably always be used in horizontal merger cases. Under certain circumstances, it is true that structural remedies may be difficult to implement. These include, but are not limited to, vertical mergers where efficiencies are large and can clearly be separated from anticompetitive actions by such remedies, cases involving dominant firms with control over essential networks or patented technologies, and instances where identifying a package of "winning" assets and acceptable buyers is difficult. Ordinarily, however, structural remedies are to be preferred for all the reasons documented in this White Paper.
• The decision to employ behavioral remedies should be based on a multi-factor test. Injunctions are most likely a more effective deterrent to anticompetitive mergers, for the reason that parties are less likely to propose a merger that they believe will be challenged than if they anticipate a likelihood of reaching a satisfactory settlement. Once it is determined that a merger is anticompetitive, a compromise that permits the merger in return for behavioral remedies should come only after considering complete rejection of the transaction and other structural remedies. This judgment should be based on an in-house consensus by well-informed litigators on the probability of success at various levels of the legal system. Thus, the case for behavioral remedies will be strongest where the chances of prevailing in court are deemed very small, the importance of establishing a principle of antitrust enforcement is insubstantial, and the need to preserve agency resources for more important activities is great.
• Given the problems inherent with arbitration, the government should look toward other methods for policing compliance with -and increasing the likelihood of successfully enforcing -a consent decree. A primary method of ensuring compliance with a consent order is often to put the burden on complainants to "tell us if there is a problem." Complainants can avail themselves of arbitration to air and settle disputes, but at some expense and uncertainty regarding the ability to appeal a decision. The need voluntarily to come forward under circumstances where retaliation is possible also undermines a compliance process that depends on victims to surface in public. This problem is likely to be complicated in mergers where both an antitrust and regulatory arbitration process is available to address disputes. If a consent order is to serve its declared purpose, better mechanisms are needed to ensure compliance and replace the competition that was lost by virtue of the merger.
• Thorough implementation, monitoring, and evaluation provisions should be built into a behavioral remedy. Compliance conditions generally state that the parties will be required to provide the government with a variety of information on request. This places the parties in a passive role in the compliance process. Future consent decrees should go farther and outline specific actions to be taken by the parties, such as the filing of periodic market monitoring and compliance reports (along with supporting data). This provides the government and the public with information on the state of the markets affected by the merger and will facilitate retrospectives on the effectiveness of behavioral remedies. Market monitors may also be required, at the merging parties' expense, to independently evaluate and report on the role of the merged firm in the market. Mechanisms for funding market monitoring include an HSR-type filing fee that is incorporated into the consent decree.
• Updated guidelines on vertical mergers are essential. Vertical merger guidelines were last updated in 1984 and do not accurately reflect either current economic understanding or the agencies' enforcement stance on vertical mergers. If behavioral remedies are to play a larger role in restructuring transactions that involve vertical issues, then there would be considerable benefit from the guidance and transparency offered by updated vertical merger guidelines that clarify the types of competitive concerns that a remedy must address.
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• One obvious and important improvement to non-discrimination and fair dealing provisions is to base them on a "commercially and competitively reasonable" standard. Incentives to pursue normal business behavior and evade nondiscrimination restraints pose significant challenges. This problem is exacerbated by the use of "commercially reasonable" provisions in consent orders. For a merged firm that possesses market power, for example, monopoly pricing might fall within the confines of such language. A "commercially and competitively reasonable" standard would be an improvement, although it would not avoid the endemic problem of monitoring and enforcement.
• "Comparability" standards set forth as part of non-discrimination conditions could result in a degradation of innovation. Antitrust agency personnel are unlikely to be equipped to make a judgment as to whether a complex technology provided by the parties is appropriately "comparable." Such a determination would challenge even the best engineers, particularly in emerging or dynamic markets. Holding a merged company to such as standard is likely to invite evasion of the restraint and slow innovation.
• The term of a remedy should be based on demonstrable progress toward the desired goal of competition or innovation. Terms that fix the length of time the consent decree will be in force are inherently arbitrary because of the uncertainty associated with dynamic markets and the difficulty of forecasting future market conditions. Since both inadequate and excessive time periods run the risk of defeating the purpose of the remedy, some criteria are needed to demonstrate achievement of desired goals. This may include whether expected innovation is occurring and/or new products brought to market.
• Behavioral remedies should be tested under the auspices of a dedicated program within the Antitrust Division's Office of General Counsel. Provisions for monitoring in the 2011 REMEDIES GUIDE are likely to be inadequate or ineffective for collecting the type and volume of data and information required to test behavioral remedies and facilitate retrospectives. Much like the antitrust agencies have collected and evaluated evidence relating to the implementation of structural remedies, a similar effort will be required for behavioral remedies.
• The 2011 REMEDIES GUIDE should be re-evaluated relatively soon. The revisions should be placed on the Antitrust Division's agenda for re-evaluation in 2015, in the light of experience with the effectiveness and administration of on-going consent orders. A program for generating supportive in-house and external analyses should be adopted early on.
